Literature DB >> 12382526

Chemoprotective potential of phase 2 enzyme inducers.

Ryan A Dick1, Thomas W Kensler.   

Abstract

In this review we summarize recent data on the use of phase 2 enzyme inducers as cancer chemopreventive agents in preclinical and clinical studies. These agents elevate the expression of genes involved in the detoxication of electrophiles and free radicals that contribute to carcinogenesis. Their mechanisms of action, efficacy and limitations are discussed. Particular attention is paid to isothiocyante and dithiolethione classes of agents, as these are the most developed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382526     DOI: 10.1586/14737140.2.5.581

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  3 in total

1.  Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.

Authors:  Lianguo Kang; Ling Ding; Zhao-Yi Wang
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

2.  Preparation of Disubstituted Phenyl Propargyl Alcohols, their Use in Oxathiolene Oxide Synthesis, and Evaluation of the Oxathiolene Oxide Products as Anticarcinogenic Enzyme Inducers.

Authors:  Maben Ying; Matthew G Smentek; Rong Ma; Cynthia S Day; Suzy V Torti; Mark E Welker
Journal:  Lett Org Chem       Date:  2009-04-01       Impact factor: 0.867

3.  Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells.

Authors:  Laurent Brard; Rakesh K Singh; Kyu Kwang Kim; Thilo S Lange; Giselle L Saulier Sholler
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.